Probes, methods of making probes, and methods of use
Embodiments of the present disclosure provide for probes, methods of using the probe, methods of making the probe, method of imaging a condition (e.g., pre-cancerous tissue, cancer, or a tumor), methods of planning resection of a brain tumor, methods of imaging a brain tumor, and the like.
1. A probe, comprising:
a nanoparticle core, a reporter compound layer disposed on the core, a silica shell consisting of polymeric silicon dioxide linking 3-mercaptopropyl-trimethoxysilane (MPTMS) moieties directly attached to the nanoparticle core surrounding the reporter compound layer and the core, and a plurality of MRI-detectable agents disposed on the silica shell; wherein the core is a photoacoustic probe having a detectable photoacoustic signal; wherein the reporter compound is a Raman-active reporter, wherein the interaction of the Raman-active reporter with the core produces a detectable vibrational signal.
2. The probe of claim 1 , wherein the core has a shape selected from a spherical shape and a rod shape.
3. The probe of claim 1 , wherein the nanoparticle core is a gold nanoparticle core and the MRI agent is Gd.
4. The probe of claim 1 , wherein the MRI agent is a plurality of Gd ions, and wherein the Gd ions are directly disposed on the encapsulant surface.
5. The probe of claim 1 , wherein the MRI agent is a plurality of Gd ions, and wherein the Gd ions are attached indirectly to the encapsulant surface via a linker.
6. The probe of claim 1 , wherein the MRI agent is a plurality of Gd ions, and wherein some of the Gd ions are attached indirectly to the encapsulant surface via a linker and wherein some of the Gd ions are disposed directly on the encapsulant surface.
7. The probe of claim 6 , wherein the ratio of the Gd directly disposed on the shell surface and Gd indirectly linked to the encapsulant surface is about 1:10 to 10:1.
8. The probe of claim 1 , wherein the Raman-active reporter is selected from: a polycyclic aromatic compound, a heteroaromatic compound, and a combination thereof.
9. The probe of claim 1 , wherein the nanoparticle core is selected from: gold, silver, and a combination thereof.
10. The probe of claim 1 , wherein the shell is composed of at least one of silica, a metallic film different from the core material, a polymer, and a polymeric chelator.
11. The probe of claim 1 , wherein the MRI agent is selected from: Gd, iron oxide, a paramagnetic CEST agent, and a combination thereof.
12. The probe of claim 1 , wherein the probe has a diameter of about 100 to 160 nm.
13. A method of imaging a brain tumor, comprising the steps of:
(a) delivering to a subject human or animal a composition comprising a multimodal nanoprobe, said multimodal nanoprobe comprising a nanoparticle core, a reporter compound layer disposed on the core, a silica shell consisting of polymeric silicon dioxide linking 3-mercaptopropyl-trimethoxysilane (MPTMS) moieties directly attached to the nanoparticle core surrounding the reporter compound layer and the core, and a plurality of MRI-detectable agents disposed on the silica shell; wherein the core is a photoacoustic probe having a detectable photoacoustic signal; wherein the reporter compound is a Raman-active reporter, wherein the interaction of the Raman-active reporter with the core produces a detectable vibrational signal;
(b) preoperatively obtaining a MRI signal from the multimodal nanoprobe in the tumorous tissue within the brain of the subject human or animal and generating from the MRI signal a first image, wherein the first image indicates a location of tumorous brain tissue and a macroscopic delineation thereof within the brain of the subject human or animal;
(c) intra-operatively obtaining a deep tissue penetration photoacoustic signal from the multimodal nanoprobe in the tumorous tissue within the brain of the subject human or animal and generating from the photoacoustic signal a second image, wherein the second image indicates the location of tumorous brain tissue within the brain of the subject human or animal;
(d) intra-operatively obtaining a Raman vibrational signal from the multimodal nanoprobe in the tumorous tissue within the brain of the subject human or animal and generating from the Raman vibrational signal a third image, wherein the third image indicates the margin of tumorous brain tissue within the brain of the subject human or animal; and
(e) intra-operatively overlaying at least two of the first, the second, and the third images with an MR image of the brain of the subject human or animal to generate an overlay image of the tumorous brain tissue within the brain of the subject human or animal by and determining from said overlay image at least one of the location and the margin of the tumorous brain tissue within the brain of the subject human or animal.
14. The method of claim 13 , wherein the nanoparticle core has a shape selected from a spherical shape and a rod shape.
15. The method of claim 13 , wherein the nanoparticle core is a gold nanoparticle core and the MRI agent is Gd.
16. The method of claim 13 , wherein the MRI agent is a plurality of Gd ions, and wherein the Gd ions are directly disposed on the encapsulant surface.
17. The method of claim 13 , wherein the MRI agent is a plurality of Gd ions, and wherein the Gd ions are attached indirectly to the encapsulant surface via a linker.
18. The method of claim 13 , wherein the MRI agent is a plurality of Gd ions, and wherein some of the Gd ions are attached indirectly to the encapsulant surface via a linker and wherein some of the Gd ions are disposed directly on the encapsulant surface.
19. The method of claim 18 , wherein the ratio of the Gd directly disposed on the shell surface and Gd indirectly linked to the encapsulant surface is about 1:10 to 10:1.
20. The method of claim 13 , wherein the Raman-active reporter is selected from: a polycyclic aromatic compound, a heteroaromatic compound, and a combination thereof.
21. The method of claim 13 , wherein the nanoparticle core is selected from: gold, silver, and a combination thereof.
22. The method of claim 13 , wherein the shell is composed of at least one of silica, a metallic film different from the core material, a polymer, and a polymeric chelator.
23. The method of claim 13 , wherein the MRI agent is selected from: Gd, iron oxide, a paramagnetic CEST agent, and a combination thereof.
24. The method of claim 13 , wherein the probe has a diameter of about 100 to 160 nm.